In a similar study, six single CTCs were isolated from a metastatic triple-negative breast cancer patient, where one CTC exhibited the same TP53 (R110 delG) mutation and one revealed a TP53 (R110 delC) mutation; the remaining four single CTCs possessed the wild-type TP53 sequence.14 This evidence concerns the gene TP53 and triple-negative breast carcinoma.